Head-to-head dimers in the zwitterion of 1-hydroxy-3-(pyrrolidin-1-yl)propylidene-1,1-bisphosphonic acid (EB 1053).
暂无分享,去创建一个
[1] T. Martin,et al. Bisphosphonates - mechanisms of action , 2000 .
[2] T. Martin,et al. Therapeutic approaches to bone diseases. , 2000, Science.
[3] G. Pirianov,et al. Bisphosphonates induce apoptosis in human breast cancer cell lines , 2000, British Journal of Cancer.
[4] Louis J. Farrugia,et al. WinGX suite for small-molecule single-crystal crystallography , 1999 .
[5] M. Nardelli,et al. PARST95 – an update to PARST: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analyses , 1995 .
[6] J. Compston. Fortnightly Review: The therapeutic use of bisphosphonates , 1994, BMJ.
[7] S. Needle,et al. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. , 1992, Journal of lipid research.
[8] D. Cremer,et al. General definition of ring puckering coordinates , 1975 .